强制性细胞内降解异抗原作为基于细胞的癌症免疫疗法的一种方式
Jean Pierre Bikorimana1, Roudy Farah1, Jamilah Abusarah2
1Department of Microbiology, Infectious Diseases and Immunology, Université de Montréal, Montréal, QC H3T1J4, Canada.
使用介质细胞 (MSC) 强制降解抗原,引发强大的抗瘤反应. 这种基于MSC的疫苗策略增强T细胞激活和控制瘤生长,提供了一个有前途的癌症治疗方法.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 在瘤学瘤学.
背景情况:
- 介酶体 stromal 细胞 (MSCs) 越来越多地被用作疫苗接种平台.
- 有效的抗原呈现对于启动强大的抗癌免疫反应至关重要.
研究的目的:
- 调查MSC中化降解序列的实验抗原的强制降解是否可以诱导强有力的抗瘤反应.
- 在固体T细胞淋巴瘤小鼠模型中评估这种基于MSC的新型疫苗策略的治疗疗效.
主要方法:
- 通过逆转录病毒基因工程创建了表达具有降解序列 (MSC-UBvR-OVA) 的抗原的MSC.
- 在体外评估抗原呈现能力和谱.
- 在具有预先确定的固体T细胞淋巴瘤的同源性免疫能力小鼠中评估治疗功效.
主要成果:
- MSC-UBvR-OVA接种引发了强大的T细胞激活,与抗原衍生的增强细胞表面呈现和线粒体活性氧化物种 (ROS) 的增加有关.
- 疫苗接种控制了小鼠的瘤生长.
- 结合疗法与基胺刺激的MSCs和抗PD-1进一步增强了通过细胞分裂介导的抗瘤效应.
结论:
- 在MSC中通过UBvR强制降解抗原是开发有效的MSC癌症疫苗的可行策略.
- 这种方法通过增强抗原处理和T细胞激活来激发强大的抗瘤反应.
- 组合疗法显示出改善癌症治疗结果的协同作用潜力.
更多相关视频
09:53Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
Published on: February 6, 2017
08:12Killer Artificial Antigen Presenting Cells KaAPC for Efficient In Vitro Depletion of Human Antigen-specific T Cells
Published on: August 11, 2014
相关概念视频
Tumor Immunotherapy
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cell-mediated Immune Responses
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
Antigen Processing Pathways
MHC Class I: Presenting Endogenous...
